单位:[1]Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China华中科技大学同济医学院附属同济医院[2]Department of Obstetrics and Gynecology, Guiyang Maternity and Child Health Care Hospital, Guiyang, Guizhou, People's Republic of China[3]Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, People's Republic of China[4]Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China
Aims: It has been demonstrated that miR-145 is expressed in primordial follicles and modulates the initiation of primordial follicle development. We aimed to explore the function of miR-145 in mouse granulosa cells (mGCs). Materials and methods: The proliferation and differentiation of GCs were examined via MTT, EDU assay, QRTPCR, ELISA and electron microscope analysis. The target of miR-145 was determined by bioinformatics analysis and luciferase reporter assay and the molecular mechanisms were examined via western blot and quantitative Real-Time RT-PCR. Key findings: We proved that down-regulation of miR-145 could inhibit GCs proliferation and differentiation. In addition, we provided evidence that Crkl was the target gene of miR-145. The miR-145 antagomir caused an increase in Crkl expression and activation of the JNK/p38 MAPK pathway. Overexpression of Crkl with pEGFPN1-Crkl vector inhibited GCs differentiation and progesterone synthesis as well as activation of the JNK/p38 MAPK pathway. Significance: Our study shows that miR-145 targets Crkl and through the JNK/p38 MAPK signaling pathway promotes the GCs proliferation, differentiation, and steroidogenesis. MiR-145 may play an important role in the ovarian physiology and pathology.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501227]; National Key Research and Development Program of China [2016YFC1302900]; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, Huazhong University of Science and Technology [5001540008]; Health and Family Planning Com-mission of HuBei Province [WJ2015MB054]
基金编号:815012272016YFC13029005001540008WJ2015MB054
语种:
外文
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2020]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2025]版:
大类|3 区医学
小类|2 区药学3 区医学:研究与实验
JCR分区:
出版当年[2019]版:
Q2MEDICINE, RESEARCH & EXPERIMENTALQ2PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者单位:[1]Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wang Shuo,Tang Weicheng,Ma Lanfang,et al.MiR-145 regulates steroidogenesis in mouse primary granulosa cells through targeting Crkl[J].LIFE SCIENCES.2021,282:doi:10.1016/j.lfs.2021.119820.
APA:
Wang Shuo,Tang Weicheng,Ma Lanfang,Yang Jun,Huang Kecheng...&Wang Shixuan.(2021).MiR-145 regulates steroidogenesis in mouse primary granulosa cells through targeting Crkl.LIFE SCIENCES,282,
MLA:
Wang Shuo,et al."MiR-145 regulates steroidogenesis in mouse primary granulosa cells through targeting Crkl".LIFE SCIENCES 282.(2021)